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ABSTRACT
Synthetic biology requires effective methods to
assemble DNA parts into devices and to modify
these devices once made. Here we demonstrate a
convenient rapid procedure for DNA fragment
assembly using site-specific recombination by
rC31 integrase. Using six orthogonal attP/attB
recombination site pairs with different overlap
sequences, we can assemble up to five DNA frag-
ments in a defined order and insert them into a
plasmid vector in a single recombination reaction.
rC31 integrase-mediated assembly is highly
efficient, allowing production of large libraries
suitable for combinatorial gene assembly strategies.
The resultant assemblies contain arrays of DNA cas-
settes separated by recombination sites, which can
be used to manipulate the assembly by further
recombination. We illustrate the utility of these
procedures to (i) assemble functional metabolic
pathways containing three, four or five genes; (ii)
optimize productivity of two model metabolic
pathways by combinatorial assembly with random-
ization of gene order or ribosome binding site
strength; and (iii) modify an assembled metabolic
pathway by gene replacement or addition.
INTRODUCTION
Synthetic biology seeks to engineer new function in biolo-
gical systems for a variety of different applications. A key
limitation in synthetic biology is the time taken to
assemble genes or other DNA parts into new devices,
pathways and systems, and to alter these assemblies
once made. The current methods for gene assembly and
systematic variation of DNA parts are far from ideal (1).
Existing assembly methods use restriction enzymes and
DNA ligases to join DNA segments together, either
sequentially (2,3) or in a single reaction (4,5), or use
homology-dependent assembly in vitro (6–9) or in vivo
(10–13). The junction sequences left by these methods
make it difficult to change individual parts of the
assembly without starting the assembly process from the
beginning again. Furthermore, most of these methods
cannot produce large libraries of variant assemblies from
large numbers of DNA parts for use in combinatorial
assembly strategies. Here we report the development of
a highly efficient, rapid and easy recombinational
assembly method (SIRA, serine integrase recombinational
assembly) that uses fC31 integrase to assemble pre-
designed pathways and devices from DNA parts. We
illustrate the use of SIRA to assemble functional meta-
bolic pathways from individual gene cassettes. Once
assembled, genes or other DNA elements can be
replaced, deleted or added at will. The assembly process
can easily incorporate multiple variants at all gene pos-
itions, randomize gene order and vary expression levels,
allowing rapid pathway optimization.
MATERIALS AND METHODS
Bacterial strains and growth
Routine bacterial growth was in LB medium (14), with
agar (15 g/l) and antibiotics (ampicillin 100 mg/ml, chlor-
amphenicol 25 mg/ml, kanamycin 50 mg/ml) added as
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required. Escherichia coli TOP10 (Life Technologies) was
used for routine transformation and maintenance of
plasmids. E. coli DB3.1 carrying the gyrA462 mutation
(15) was used for propagation of plasmids containing
the ccdB gene. E. coli DS941-Z1, carrying the lacI and
tetR genes from DH5aZ1 (16) P1 transduced into
DS941 (17), was used for expression of the violacein bio-
synthetic pathway.
E. coli cells were made chemically competent with
50mM calcium chloride and transformed using standard
methods (14). Transformation routinely yielded between
2 106 and 6 106 transformants per mg pUC19 plasmid
DNA. Electrocompetent TOP10 E. coli were prepared by
repeated washes in ice-cold 10% glycerol (14) and
electroporated using a Biorad micro pulser apparatus
set on EC2 (2.5 kV, 5.9ms time-constant), in a 2mm
cuvette according to the manufacturer’s instructions.
Electroporation routinely yielded 1 108 transformants
per mg pUC19 plasmid DNA.
Pantoea ananatis (DSM number 30080; formerly
Erwinia uredovora), containing the carotenoid biosynthetic
gene cluster (Genbank accesssion number D90087) and
Chromobacterium violaceum (DSM number 30191), con-
taining the violacein biosynthetic gene cluster (Genbank
accession number NC_005085 coordinates 3558964-
3566288) were obtained from the DSMZ German
collection of microorganisms and cell cultures. Genomic
DNA was purified from these organisms using the
QIAGEN Gentra Puregene kit according to the manufac-
turer’s instructions for Gram-negative bacteria.
Plasmid construction
The plasmids used in this study are shown in Table 1.
Oligonucleotides used in their constructions are shown
in Supplementary Table S1.1. Biobricks were obtained
from the registry of standard biological parts (http://
parts.igem.org). Full plasmid sequences are available on
request. pSIRA vectors were based on pSB1A3, an ampi-
cillin-resistant pMB1 origin vector containing the P1010
ccdB biobrick (3). pSIRA1 was constructed by inserting
attB-RX-TT top and bottom strands between EcoRI and
XbaI sites of pSB1A3, and attB-PS-TC top and bottom
strands between PstI and SpeI. pSIRA2 was constructed
in the same way with attP-RX-TT and attP-PS-TC oligo-
nucleotides, whereas pSIRA3 used attB-RX-TT and attP-
SP-TC oligonucleotides. pL-lacO and pL-tetO promoters
(16) were made by annealing pL-Eco top and bottom
strands with either pL-tet or pL-lac top and bottom
strands and inserted into the EcoRI site of pSIRA1 to
produce pSIRA4 and pSIRA5, respectively. The crtB,
crtE, crtI and crtY genes were amplified together with
designed ribosome binding sites (RBS) by PCR using
Phusion polymerase (New England Biolabs) and the
primers shown in Supplementary Table S1.2 and
inserted into pCR2.1-TOPO by TOPO-TA cloning (Life
Technologies) to create pCM1, pCM2, pCM3 and pCM4,
respectively. p-ccdB-CmR was constructed by inserting the
P1004 chloramphenicol resistance biobrick as an XbaI-
PstI fragment into SpeI-PstI-digested pSB1A3 already
containing the P1010 ccdB biobrick.
PCR
Fragments for gene assembly were amplified by PCR
using Phusion high-fidelity DNA polymerase (New
England Biolabs) with the primers and templates shown
in Supplementary Table S1.3. Reactions (50 ml) generally
contained 1HF Phusion buffer with an additional
0.5mM MgCl2, 200mM of each deoxynucleotide triphos-
phate, 3% dimethyl sulfoxide, 500 nM of each primer,
1 ng of plasmid template or 50 ng genomic template
and 0.5ml Phusion polymerase. Reactions were subjected
to an initial denaturation step of 98C for 1min, followed
by 30 cycles of 98C for 20 s, 55C for 30 s and 72C for
60–120 s. After a final step of 72C for 10min, products
were separated on 1% agarose gels in tris-acetate buffer
[40mM Tris base, 20mM acetic acid, 1mM ethylenedia-
minetetraacetic acid (EDTA)], stained with ethidium
bromide, excised under long-wave ultraviolet illumination
and purified using a QIAquick gel extraction kit
(QIAGEN) according to the manufacturer’s instructions,
with an extra wash step with 0.5ml buffer PE. Purified
PCR products were quantified by agarose gel electrophor-
esis with known DNA standards or by measuring UV
absorbance at 260 nm.
Table 1. Plasmids used in this study
Plasmid name Description Resistance Reference
pCR2.1-TOPO TOPO TA cloning vector AmpR KanR Life technologies
pSB1A3 pMB1 ori biobrick cloning vector containing the P1010 ccdB
cell death biobrick
AmpR Registry of biological parts (3)
pSW23 suicide cloning vector oriV(R6Kgamma) CmR Demarre et al. (18)
pSW29 suicide cloning vector oriV(R6Kgamma) KanR Demarre et al. (18)
pCM1 P. ananatis crtB PCR product in pCR2.1-TOPO AmpR KanR This work
pCM2 P. ananatis crtE PCR product in pCR2.1-TOPO AmpR KanR This work
pCM3 P. ananatis crtI PCR product in pCR2.1-TOPO AmpR KanR This work
pCM4 P. ananatis crtY PCR product in pCR2.1-TOPO AmpR KanR This work
p-ccdB -CmR pSB1A3 with P1010 (ccdB) and P1004 (CmR) AmpR CmR This work
pSIRA1 attB-TT attB-TC SIRA vector based on pSB1A3 AmpR This work
pSIRA2 attP-TT attP-TC SIRA vector based on pSB1A3 AmpR This work
pSIRA3 attB-TT attP-TC SIRA vector based on pSB1A3 AmpR This work
pSIRA4 pSIRA1 with pL-tet upstream of attP-TT AmpR This work
pSIRA5 pSIRA1 with pL-lac upstream of attP-TT AmpR This work
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Proteins
The fC31 integrase and the gp3-encoded recombination
directionality factor (RDF) were purified as described by
Olorunniji et al (19). Proteins were diluted in a buffer
containing 25mM Tris–HCl (pH 7.5), 1mM DTT, 1M
NaCl and 50% (vol/vol) glycerol and stored at 20C.
Assembly reactions
For SIRA reactions, each PCR fragment (final concentra-
tion 5 nM) and vector (final concentration 3 nM)
were mixed together in a 20 ml reaction containing 10mM
Tris–HCl (pH 7.5), 5mM spermidine3HCl, 2mM
dithiothreitol, 0.1mM EDTA, 0.1mg/ml bovine serum
albumin and between 0 and 20% (vol/vol) ethylene
glycol. Recombination was initiated by the addition of
2 ml of 2 mM fC31 integrase in protein dilution buffer.
For attL attR recombination, equal volumes of 4 mM
integrase and 8 mM RDF were pre-mixed in protein
dilution buffer and incubated on ice for 10min, and reac-
tions were started by adding 2 ml of this mixture. Reactions
were incubated at 30C for the indicated time (5min–24 h)
and then stopped by heating to 75C for 10min. For
chemical transformation, 2 ml of heat-treated assembly
reaction was added directly to 100 ml of competent E. coli
cells. For electroporation, DNA was first precipitated by
the addition of 2.2 volumes of 100% ethanol in the
presence of 0.3M sodium acetate and 1 mg of yeast
tRNA (Sigma-Aldrich). Precipitated DNA was re-
dissolved in 10 ml of distilled H2O, and 2 ml of this DNA
was used to transform 30 ml of electrocompetent cells.
RESULTS
Recombinational cloning using rC31 integrase
Bacteriophage fC31 integrase inserts the phage genome
into its host’s DNA by recombining specific 46 bp attP
and attB DNA sequences found in the phage and host
genomes, respectively (20,21). Integrase makes staggered
cuts on either side of a central two base-pair ‘overlap’
sequence in both attP and attB (22), exchanges the result-
ing half-sites and rejoins them to form two new sites, attL
and attR (Figure 1A). Recombination between attP and
attB is highly efficient both in vitro and in vivo. In the
presence of integrase alone, the products of recombination
between attP and attB (attL and attR) do not recombine
further, and the reaction is highly directional (23).
However, the addition of the phage-encoded recombin-
ation directionality protein (RDF) allows efficient
recombination between attL and attR and inhibits recom-
bination between attP and attB (24).
The central 2 bp overlap sequences of two sites must
match perfectly for efficient recombination, but their
precise sequence has little effect on the efficiency of recom-
bination (25,26). Throughout this article, we refer to attP
with the 2 bp overlap sequence 50-TT on the top strand
(and 50-AA on the bottom strand) as attPTT and so
forth. Thus, attPTT recombines efficiently only with
attBTT, attPTC with attBTC and so on. The 2 bp overlap
sequence also determines the polarity of attP and attB
sites, so that for instance attPTT will recombine with a
reversed attBAA site, because the 50-TT on the top
strand of attPTT matches the 50-TT on the bottom
strand of attBAA (25). Furthermore, att sites with symmet-
rical central 2 bp overlap sequences (e.g. attPTA and
attBTA) will recombine in both possible relative orienta-
tions. Therefore, six different matched attP/attB pairs that
recombine only with each other in a defined orientation
can be made using the non-symmetric overlap sequences
(top strand/bottom strand) 50-TT/50-AA, 50-CT/50-AG,
50-GT/50-AC, 50-CA/50-TG, 50-CC/50-GG and 50-TC/
50-GA (Figure 1B, Supplementary Figure S1A). Because
each attP site recombines with its matching attB site but
not with any other, we refer to these matched att site pairs
as ‘orthogonal’.
A
B
C
D
Figure 1. The SIRA process. (A) In the presence of fC31 integrase
alone, attP and attB sites recombine to form attL and attR. The
reaction can be reversed in the presence of the RDF. Integrase cuts
both strands near the centres of the sites at positions staggered by two
nucleotides. These central overlap sequences define the left–right
polarity of the sites and must match in recombining sites. (B) Six
possible asymmetric central overlap sequences can be used to produce
pairs of orthogonal sites that will recombine only with each other and
will be cut and rejoined in a specific orientation. The colour code
shown here is used throughout the rest of the article. (C) RBS
sequences and att sites can be incorporated into DNA fragments by
PCR. Recombination sites are in inverted repeat to reduce complemen-
tarity between forward and reverse PCR primers for each cassette.
(D) Inserting a single DNA fragment (here encoding a KanR determin-
ant) into a vector by SIRA cassette exchange. attP sites at the ends of a
linear DNA fragment recombine with matching attB sites in the pSIRA
vector, replacing the conditionally lethal ccdB gene with the linear
fragment. The desired product can be selected by its ability to trans-
form a ccdB-sensitive E. coli strain.
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Using these six orthogonal recombination site pairs,
we have developed a recombinational assembly and
cloning strategy. This SIRA strategy uses plasmid
vectors containing two att sites with different central
dinucleotides, flanking a conditionally lethal ccdB gene.
Recombination between the sites on the plasmid and
matching sites at either end of a linear DNA fragment
replaces ccdB with the linear fragment (Figure 1D). The
product can easily be isolated by selection for loss of ccdB.
We have generated a set of pSIRA vectors containing dif-
ferent att sites and regulated promoters to express the
inserted genes (Table 1).
We first demonstrated that purified fC31 integrase
can be used for efficient insertion of a single linear DNA
fragment into a plasmid vector by cassette exchange.
A kanamycin resistance gene flanked by attP sites with
two different central dinucleotides (attPTT and attPTC)
was generated by PCR (Figure 1C) and mixed with
pSIRA1, which carries attBTT and attBTC sites flanking
ccdB (Figure 1D). After reacting for 1 h with fC31
integrase, the reaction products were electroporated into
TOP10 E. coli cells and transformants were selected for
resistance to ampicillin and then tested for resistance to
kanamycin. All transformants tested (100/100) were resist-
ant to kanamycin (Table 2; Supplementary Figure S2),
confirming that the linear DNA fragment was efficiently
exchanged into pSIRA1. This single-gene SIRA reaction
routinely gave 8 107 colonies per mg of vector DNA,
corresponding to 9 106 colonies from a single SIRA
cloning reaction (Table 2). Analysis of plasmid DNA
from a sample of colonies confirmed that they contained
the kanamycin resistance gene from the PCR product in
single copy with a defined orientation, as expected if each
attP can recombine only with its matching attB site (data
not shown). The reaction was efficient enough that calcium
chloride transformation could be used instead of electro-
poration (Table 2), and a five-minute SIRA reaction was
sufficient to clone a single DNA fragment (Supplementary
Figure S2). Similar results were obtained with kanamycin
or chloramphenicol resistance cassettes flanked by two
attB sites or one attP and one attB site, with pSIRA2
and pSIRA3, respectively (Supplementary Figure S2).
A small number of colonies lacking the expected antibiotic
resistance cassette were detected with pSIRA3 (containing
attBTT and attPTC), suggesting a low level of intramolecu-
lar recombination between the mismatched attP and attB
sites in the vector, leading to deletion of ccdB
(Supplementary Figure S2).
Metabolic pathway assembly by SIRA
We designed SIRA schemes to assemble three, four or five
DNA fragments (‘cassettes’) into a plasmid vector in a
single recombination reaction (Figure 2B). Each cassette
is flanked by either two attP sites or two attB sites, except
in the four-gene strategy, where one cassette has one attP
and one attB. The central overlap sequences of the att sites
are chosen such that each site can recombine with only
one other type of site in the mixture. Recombination
between all matching attP–attB pairs joins the cassettes
together end-to-end in a specific order and inserts the re-
sulting linear assembly into the pSIRA vector, replacing
ccdB (Figure 2B).
To test these SIRA schemes, we assembled functional
metabolic pathways from multiple genes. The carotenoid
biosynthetic pathway of Pantoea ananas [E. uredovora]
produces zeaxanthin (yellow) via lycopene (red) and
b-carotene (yellow–orange) (27). Three genes from
P. ananas (crtE, crtB and crtI) are sufficient to produce
lycopene in E. coli, four genes (crtE, crtB, crtI and crtY)
produce b-carotene and five genes (crtE, crtB, crtI, crtY
and crtZ) produce zeaxanthin (Figure 2A).
The five carotenoid biosynthetic open reading frames
were each amplified by PCR, with designed RBS
upstream of their ATG start codons and terminal
attP or attB incorporated in the PCR primers. The com-
binations of DNA fragments required for three-, four- or
five-gene assemblies were mixed together with pSIRA1.
Following incubation with fC31 integrase, the reactions
were electroporated into E. coli TOP10. Plasmids that
Table 2. Efficiency of SIRA reactions
Number of fragments
assembled
Pathway Reaction
time
Transformants per
20 ml
reaction (CaCl2)
a
Transformants
per 20 ml reaction
(electrocompetent)b
Transformants
per mg vector DNAc
Percent correctly
assembled (%)
1 KanR 1 h 2 104 9 106 8 107 100
3 crtBEI 4 h 4 103 8 105 7 106 59
3 crtBEI 22 h 1 104 1 106 9 106 87
4 crtBEIY 24 h 9 103 1 106 9 106 37
5 crtBEIZY 22 h 9 103 7 105 6 106 18
5 vioABCDE 22 h 2 103 4 105 4 106 18
Replacementd crtBEI*ZY 22 h 9 103 4 105 1 106 94
Additione crtI-idi-dxs 16 h 7 102 1 105 3 105 48
aNumber of transformants obtained from a 20 ml assembly reaction introduced into CaCl2 TOP10 competent cells (106 transformants per mg
pUC19).
bNumber of transformants obtained from a 20 ml assembly reaction introduced into electrocompetent TOP10 cells (108 transformants per mg
pUC19).
cNumber of transformants obtained per mg of vector DNA using electrocompetent TOP10 cells (108 transformants per mg pUC19).
dReplacement of the crtI gene in the 5-gene crtBEIZY assembly with a Phusion-amplified crtI cassette, after first replacing crtI with the ccdB-
CmRcassette.
eReplacement of the crtI gene in the 5-gene crtBEIZY assembly with crtI, idi and dxs, after first replacing crtI with the ccdB-CmR cassette.
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had lost the lethal ccdB gene, and therefore should contain
the desired pathway, were selected by growth
of transformants on medium containing ampicillin.
The efficiency of assembly was measured as the percentage
of coloured colonies obtained. As the number of frag-
ments in the assembly was increased from three to five,
both the number of colonies obtained and the efficiency of
assembly decreased (Table 2; Figure 2). This decrease in
efficiency was overcome by increasing the incubation
time and adding ethylene glycol to the assembly reaction
(Table 2; Supplementary Figure S3). A 22-h three-gene
assembly reaction in the presence of 5% ethylene glycol
yielded 1 106 colonies (7 106 colonies/ mg vector
DNA), nearly 90% of which produced lycopene (red
colonies) and contained plasmid with the expected struc-
ture, as confirmed by restriction analysis and DNA
sequencing of plasmid DNA. Four- and five-gene
assembly reactions gave nearly as many colonies (1 106
and 7 105, respectively), of which 18–37% produced the
predicted coloured carotenoids and contained plasmids
with the expected structure (Table 2; Figure 2B). The
majority of incorrectly assembled plasmids contained a
single gene from just one end of the desired assembly.
These can be explained by recombination between one
attB on pSIRA1 and a matching attP from the first or
last cassette in the assembly, and mismatched recombin-
ation between the attP site at the other end of the cassette
with the second attB from the vector. Although not a
major problem for assembly reactions with pSIRA1, re-
combination between mismatched sites probably accounts
for the poor efficiency of assembly reactions using
pSIRA3, where intramolecular recombination between
mismatched attBTT and attPTC sites can lead directly to
deletion of ccdB (Supplementary Figures S3).
Substituting and adding genes at specific positions within
the assembly
The SIRA strategies described earlier in the text produce
arrays of gene cassettes separated by attL sites, each with
a different overlap sequence (Figure 3A). In the presence
of integrase and RDF (fC31 Gp3) (24), each attL will
recombine with a matching attR site. This recombination
can potentially be used to replace any chosen DNA
segment in the array. In practice, we found that direct
replacement of a gene in the array by attL attR recom-
bination was less efficient than the original attP attB
SIRA reactions. We have observed DNA cleavage at
attL sites in assemblies in the presence of integrase and
RDF, presumably due to abortive recombination between
mismatched attL sites in the array, which could cause
these reduced efficiencies. To overcome this problem, we
developed a two-step replacement strategy. A chosen
segment of the assembly is first replaced with a selectable
ccdB-CmR cassette, using attL attR recombination. The
ccdB-CmR cassette, now flanked by attB sites, can then be
replaced with one or more DNA cassettes in an
A B
Figure 2. Assembly of 3-, 4- and 5-gene carotenoid biosynthetic pathways. (A) The E. coli host genes idi and dxs encode enzymes necessary for the
production of IPP and DMAPP. IPP and DMAPP are converted to geranyl pyrophosphate (GPP) and farnesyl pyrophosphate (FPP) by further
E. coli enzymes. The products of the crtE, crtB, crtI, crtY and crtZ genes from P. ananas convert FPP via geranylgeranyl pyrophosphate (GGPP)
and phytoene to the coloured carotenoids lycopene (red), b-carotene (yellow–orange) and zeaxanthin (yellow). (B) Assembly of the three-gene
lycopene, four-gene b-carotene and five-gene zeaxanthin biosynthetic pathways by SIRA. The diagrams show the arrangement of att sites used
on each fragment for ordered assembly of genes into pSIRA1. The photographs show cell pellets from one correctly assembled construct (coloured)
and one incorrectly assembled construct (white) for each pathway. The percentages of transformant colonies that were coloured or white are shown
below each pellet. Cell pellets from 4- and 5-gene assemblies had similar colours, but restriction analysis confirmed that plasmids from these reactions
all had the expected 4- and 5-gene structures.
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attP attB SIRA reaction with integrase alone. Under
these conditions, the remaining attL sites in the array
are essentially inert and do not interfere with the reaction.
To illustrate how this procedure can be used to replace
one gene with a library of gene variants, we replaced the
wild-type crtI gene in the crtBEIZY zeaxanthin biosyn-
thetic pathway with a mutagenized library of crtI genes.
The crtI gene was first replaced with the ccdB-CmR
cassette flanked by appropriate attR sites (Figure 3A),
using fC31 integrase and RDF. Selection for
chloramphenicol-resistant colonies in a ccdB-tolerant
E. coli strain yielded hundreds of colonies. Ten of ten
transformants examined carried the expected plasmid
with crtI replaced by the ccdB-CmR cassette flanked by
attB (Figure 3B). The ccdB-CmR cassette was then
replaced by a Phusion- or Taq-polymerase amplified crtI
cassette carrying appropriate attP sites in a standard
SIRA reaction (Figure 3B), yielding >105 colonies for
both Phusion and Taq (Table 2). In all, 94% of colonies
obtained with the high-fidelity Phusion polymerase had a
functional zeaxanthin biosynthetic pathway as detected by
production of yellow-coloured colonies, whereas only
65% of colonies from the mutagenic Taq reaction were
coloured. DNA sequencing revealed that the colourless
colonies contained plasmids with the expected
(crtBEIZY) structure, but with mutations in crtI consist-
ent with error-prone PCR.
The attB sites produced by replacing one gene in an
assembly with the ccdB-CmR cassette could also be used
to incorporate a further three, four, or five genes, yielding
seven-, eight- or nine-gene assemblies (Figure 3C). To
demonstrate this, we took the zeaxanthin metabolic
pathway in which crtI had already been replaced with
the ccdB-CmR cassette (Figure 3B) and added three
linear PCR products, containing the E. coli idi and dxs
genes and a new copy of crtI (Figure 3C). The idi and
dxs genes are required for the synthesis of isopentenyl
pyrophosphate (IPP) and dimethylallyl pyrophosphate
(DMAPP), precursors in the synthesis of carotenoids
(Figure 2). Overexpression of these enzymes in E. coli is
reported to increase the available pools of these intermedi-
ates and thus increase carotenoid yields (28–31). SIRA
reactions with fC31 integrase efficiently assembled these
three genes into the zeaxanthin biosynthetic pathway,
yielding plasmids with eight genes in the expected order,
with an insert size of 7.8 kb (Figure 3C; Table 2). E. coli
cells containing the full eight-gene assembly grew more
vigorously than those containing just crtBEIZY, and
were more intensely coloured, suggesting an increased
yield of zeaxanthin (Figure 3D).
Varying the order of genes in the assembly
The assemblies described here have an artificial operon
structure, with all genes in the same orientation,
transcribed from a single upstream promoter. In this struc-
ture, genes closest to the promoter will typically be
expressed at a higher level than those further away (32).
Therefore, it should be possible to adjust the expression
levels of the individual genes in an assembly by changing
the order of genes in the operon. To illustrate this we used
SIRA to assemble the three-gene lycopene biosynthetic
pathway in all possible gene orders. Versions of each
lycopene biosynthetic gene (crtB, crtE and crtI) were
produced by PCR, with different terminal att sites to
specify position one, position two or position three in a
three-gene assembly (Figure 4A). By reacting one crtB
fragment, one crtE fragment and one crtI fragment with
pSIRA1, we easily assembled all six possible orders of these
three genes (Figure 4B). Overexpression of the lycopene
A
B
C
D
Figure 3. Replacement of a single gene in an assembly with 1 genes.
(A) A ccdB-CmR cassette flanked by attR sites matching the gene to be
replaced is produced by PCR. The chosen gene is then replaced using
attL attR recombination. (B) The product of this reaction contains
two attB sites, and can be selected by chloramphenicol resistance in a
ccdB-tolerant E. coli strain. The two attB sites can then recombine with
matching attP sites to carry out a replacement reaction. (C) The two
attB sites can be used to add multiple DNA cassettes using conven-
tional SIRA assembly strategies. In both cases, the desired reaction
products are selected by loss of the lethal ccdB gene. (D) A random
selection of transformants from the reaction shown in (C) was patched
onto solid media to assay carotenoid production. Approximately 50%
of colonies contained the expected idi, dxs and crtI genes between crtE
and crtZ and were more intensely coloured than those containing crtI
alone.
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biosynthetic pathway has been reported to be toxic to
E. coli, possibly because lycopene production diverts inter-
mediates from essential metabolic pathways (33).
Carotenoid yield and toxicity have also been reported to
vary with temperature, with optimal lycopene production
and lowest toxicity at 28–30C (33–35) Assembly reactions
for each gene order were transformed into E. coli TOP10,
and transformants were incubated at either 28C or 37C.
Assembly reactions for five of the six possible gene orders
transformed E. coli efficiently at 37C (Figure 4C), and
60–80% of transformant colonies were red (Figure 4D).
One gene order (crtIEB) gave few colonies and a much
lower frequency of red colonies when transformants were
selected at 37C (Figure 4C; D) suggesting that this gene
order is toxic to E. coli at 37C. To confirm this, the plating
efficiency of cells containing each gene order in pSIRA1
was measured at 30 and 37C. Gene orders crtBIE and
crtIEB plated poorly at 37C and gave noticeably smaller
colonies than the other gene orders at 30C (Figure 4E).
There were also clear differences in lycopene production
levels for the different gene orders; for example, crtBEI
gave noticeably paler colonies than crtEBI at 30C. Thus,
changing the order of lycopene biosynthetic genes in
pSIRA1 had clear phenotypic effects, and varying gene
order could be a useful way to optimize production from
biosynthetic pathways.
To select an optimal gene order, itmight be advantageous
to produce a library containing all possible gene orders. To
do this, we reacted all nine crt gene cassettes (as described
earlier in the text) with pSIRA1 in a single reaction. This
reaction should produce assemblies of three genes in
pSIRA1, with any one of the three crt genes at each
position (27 combinations in total, of which 6 combinations
will contain one copy of each gene; Figure 4A). When the
reaction products were transformed into E. coli, 28% of
transformants formed red colonies at 28C, roughly as
expected (6/27=22%) (Figure 4D). We verified that
plasmids isolated from red colonies contained all three
lycopene genes in all possible orders, whereas plasmids
from white colonies contained other combinations of
three cassettes (e.g. crtB-crtB-crtI; data not shown).
Optimization of biosynthetic pathways by assembly with
degenerate RBS
Another way to optimize expression levels of the different
enzymes in a metabolic pathway is to vary the RBS of the
A C
D
E
B
Figure 4. Assembly of lycopene biosynthetic operon in all possible gene orders. (A) The three genes for lycopene biosynthesis were assembled in all
possible gene orders in pSIRA1. Each gene (crtB, crtE and crtI) was amplified by PCR with primers containing att sites specifying position 1 (attPTT
and attPCT), position 2 (attBCT and attBGT) or position 3 (attPGT and attPTC). By picking one gene for each position, all gene orders were
assembled. Alternatively, by mixing all nine fragments in a single reaction, all possible gene orders are produced. The positions of AlwNI sites
are indicated by red lines. (B) AlwNI restriction digests of representative plasmids containing crtB, crtE and crtI in each possible gene order. Gene
orders are indicated above each lane as BEI, BIE, EBI, EIB, IBE and IEB. (C) Assembly reactions were set up in integrase reaction buffer with 5%
ethylene glycol and 200 nM fC31 integrase and were incubated at 30C for 24 h. Samples of each reaction mixture (1ml) were used to transform
chemically competent TOP10 cells, spread on LB-agar plates containing ampicillin and grown for 16 h at 37C or 40 h at 28C. The histogram shows
the total number of colonies obtained for each transformation. (D) Randomly chosen transformant colonies were streaked on plates containing
ampicillin and grown to assay for lycopene production. The histogram shows the percentage of colonies producing lycopene. (E) Overnight cultures
of TOP10 E. coli carrying plasmids with crtB, crtE and crtI in each possible gene order were diluted 104-fold in LB broth, plated in 10 ml spots and
incubated overnight at 30C and 37C to display their colony formation and lycopene production phenotypes.
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genes in the pathway. Because we had observed toxic
effects with lycopene overproduction, we used a different
pathway to illustrate this approach. The violacein biosyn-
thetic pathway from the Gram-negative bacterium
C. violaceum produces a purple compound derived from
tryptophan in a pathway requiring the activity of five
enzymes encoded by vioA, vioB, vioC, vioD and vioE
(36,37). These genes range in size from 576 to 2997 bp,
and the total pathway is encoded on 7.5 kb of DNA.
A prototype violacein biosynthetic pathway was built by
amplifying the five vio genes directly from C. violaceum
genomic DNA, using PCR primers incorporating
designed RBS sequences and the required attP or attB
sites. The resulting gene cassettes were assembled
directly into pSIRA1 using fC31 integrase, yielding pale
purple colonies (18% of all colonies; Table 2) containing
the expected plasmid with all five vio genes. Starting from
PCR primers and C. violaceum genomic DNA, it took just
2 days to obtain the correctly assembled functional
pathway.
Each of the vio genes was then amplified with primers
incorporating degenerate RBS sequences (Figure 5A). The
primers were designed to give 16 different RBS sequences
for each gene, with predicted translation rates ranging
from 100 to 10 000 units according to the RBS calculator
software of Salis et al. (38). The PCR products were
assembled into pSIRA5 [in which transcription is
regulated by isopropylthio-b-galactoside (IPTG)] and
electroporated into ccdB-sensitive E. coli. Colonies
ranging in colour from light to intense purple were
obtained on plates containing IPTG (Figure 5C). All
colonies contained plasmids of the expected structure
(data not shown) and violacein production was IPTG-
inducible (Figure 5C). The RBS sequences were deter-
mined from seven representative plasmids and were
shown to have different sequences consistent with the de-
generate primers used. The predicted RBS strength was
calculated for all genes in these seven pathways. The
results suggest that vioA need not be highly expressed
for high levels of violacein production, whereas low
levels of vioD expression can be limiting (Figure 5C).
DISCUSSION
We have shown here that fC31 integrase can be used to
rapidly insert one, three, four or five genes or other DNA
fragments in any chosen arrangement directly into a SIRA
plasmid vector. We note that other serine integrases could
substitute for fC31 integrase in all of the DNA manipu-
lations shown here. Use of 2 integrases would allow the
introduction of further orthogonal attP/attB pairs and
would potentially allow the assembly of larger numbers
of DNA segments in a single reaction.
The speed with which assemblies can be designed and
produced by SIRA allows for rapid prototyping of meta-
bolic pathways. Unlike other assembly methods, there is
no need to subclone fragments into plasmid vectors before
assembly or to remove internal restriction sites from
within the DNA fragments. Assemblies can be easily
modified by substituting 1 DNA segments with natural
or artificial variants or by adding regulatory sequences or
more genes at chosen locations.
The efficiency of SIRA facilitates the production of
large combinatorial libraries with multiple variants of
each DNA cassette at each position. One-fragment
SIRA reactions routinely yield 8 107 transformants per
mg of vector DNA by electroporation (Table 2), higher
than reported for homology-based cloning strategies
such as Gibson assembly (7), SLiCE (8) and SLIC (6).
Furthermore, the efficiency of SIRA holds up well
compared with these methods as the number of DNA
fragments is increased (Table 2).
The attL sites flanking the components of SIRA
assemblies, each with different overlap sequences, could
be used to move the complete assembly, or sub-assemblies,
from one location to another. Site-specific recombination
could shuttle assemblies between vectors with different
antibiotic resistances, host ranges, or regulated promoters,
or deliver metabolic pathways and devices to genomic
‘landing pads’ in chassis organisms.
Site-specific recombination has been used previously in
a number of different approaches to insert DNA frag-
ments into plasmid cloning vectors (39–43). However, to
the best of our knowledge, this study is the first time that
site-specific recombination has been used to assemble
A
B
C
Figure 5. Assembly of the violacein biosynthetic pathway with degen-
erate RBS sequences. (A) Degenerate RBS sequence used for each gene
in the violacein biosynthetic pathway. To obtain an appropriate range
of predicted RBS strengths (37), the RBS sequences for vioB and vioD
had AAAAT and ACAAA, respectively (changed sequences are shown
boxed), rather than AAAAA upstream of the ATG. (B) Structure of
the assembled synthetic vio operon, transcribed from an IPTG-
regulated pL-lacO promoter in pSIRA5. (C) Phenotype of colonies
containing vio assemblies with different RBS sequences at each gene,
in the absence or presence of 0.1mM IPTG. The table shows the pre-
dicted RBS strengths (arbitrary units) (37) for each gene in the operon.
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multiple genes into fully functional metabolic pathways.
SIRA could easily be adapted for the assembly of
synthetic genetic circuits or to generate translational
fusions from multiple gene segments (e.g. to produce
novel polyketide synthases from multiple enzymatic
modules). Furthermore, SIRA is a highly flexible technol-
ogy, which should be adaptable to many other applica-
tions in metabolic engineering and synthetic biology.
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